Wird geladen...

Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review

Epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly improved the response of non-small cell lung cancer (NSCLC) with EGFR-mutant patients. However, these patients inevitably come cross acquired resistance to EGFR-TKIs. The transformation of lung adenocarcinoma to s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Biol Ther
1. Verfasser: Liu, Yangyang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2018
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5927699/
https://ncbi.nlm.nih.gov/pubmed/29461911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1435222
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!